Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tuck	6/1/2007 4:59:19 PM
	of 946

>>WASHINGTON, June 1 (Reuters) - Cell Therapeutics Inc. (CTIC.O: Quote, Profile , Research) filed on Friday with regulators to periodically sell up to $150 million in common and preferred stock, debt securities, and warrants. The company said in a registration statement with the U.S. Securities and Exchange Commission that it plans to use the proceeds from the offering for clinical development of drug candidates, commercialization activities, and general corporate purposes. Under a shelf registration, a company may sell securities in one or more separate offerings with the size, price and terms to be determined at the time of sale.<< Classic Friday afternoon sneak attack. No PR from the company yet, just the filing. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next